Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06203730
Other study ID # LYZhang
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date July 1, 2024

Study information

Verified date April 2024
Source Jiangsu Taizhou People's Hospital
Contact Liyuan Zhang, Master
Phone 86 + 17851358412
Email zhangliyuan20230419@njmu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims explored the effectiveness of dual psychological intervention strategies in improving the quality of life of MHD patients based on the theoretical guidance of double ABC-X model. To provide a scientific and effective dual psychological intervention strategy for MHD patients and their caregivers, in order to improve the quality of life of MHD patients, and to provide a reference for nurses in clinical blood purification centers to implement psychological intervention.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date July 1, 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The inclusion criteria of MHD patients were: (1) meeting the diagnostic criteria of CKD; (2) Maintenance hemodialysis at the blood purification center of our hospital for more than 3 months; (3) over 18 years of age; (4) Volunteer to participate in this study. - MHD caregiver inclusion criteria: (1) over 18 years of age; (2) Responsible for the main care tasks of MHD patients; (3) Volunteer to participate in this study. Exclusion Criteria: - Exclusion criteria for MHD patients: (1) Patients with cognitive impairment or audio-visual impairment unable to communicate normally; (2) Patients diagnosed with mental illness or who are receiving medication or psychotherapy for depression. - MHD caregiver exclusion criteria: (1) Caregivers with cognitive impairment or audiovisual impairment unable to communicate normally; (2) Caregivers suffering from serious heart, brain, liver, kidney and other important organ diseases; (3) carers or paid carers.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
dyadic psychological intervention strategy
an intervention strategy for both patients and caregivers that combines psychotherapy techniques and health management

Locations

Country Name City State
China Taizhou People's Hospital Taizhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Jiangsu Taizhou People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary quality of life of patients with MHD The Kidney Disease Quality of Life 36-item Short Form (KDQOL-36™) was used to measure quality of life in patients with MHD "Baseline" and "Immediately after the intervention"
Primary anxiety of patients with MHD The hospital anxiety and depression scale (HADS) was used to measure anxiety in patients with MHD "Baseline" and "Immediately after the intervention"
Primary depression of patients with MHD The hospital anxiety and depression scale (HADS) was used to measure depression in patients with MHD "Baseline" and "Immediately after the intervention"
Secondary anxiety of caregivers burden The hospital anxiety and depression scale (HADS) was used to measure anxiety in caregivers "Baseline" and "Immediately after the intervention"
Secondary depression of caregivers The hospital anxiety and depression scale (HADS) was used to measure depression in caregivers "Baseline" and "Immediately after the intervention"
Secondary caregivers'burden The Zarit Caregiver Burden Interview (ZBI) was used to measure caregivers' burden "Baseline" and "Immediately after the intervention"
Secondary Caregiving competence of caregivers The Caregiving Competence Scale (CCS) was used to measure caregiving competence of caregivers "Baseline" and "Immediately after the intervention"
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05978479 - The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills N/A
Completed NCT06022835 - Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis N/A
Completed NCT05540457 - Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis) N/A
Recruiting NCT04046042 - Virtual Reality Intradialysis: Last vs. First Part of the Session N/A
Not yet recruiting NCT04527640 - Effects of Synbiotics Supplementation on the Uremic Toxin Indoxyl Sulfate Level and Constipation in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT05947708 - The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 N/A
Recruiting NCT05735743 - MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence N/A
Completed NCT04505462 - Dietary Therapy in Dialysis Patients N/A
Active, not recruiting NCT04546958 - Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia N/A
Recruiting NCT04286477 - The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT
Completed NCT04487301 - A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Recruiting NCT05677555 - Colchicine and Inflammation in Hemodialysis Patients Phase 2
Completed NCT04789876 - Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia N/A
Completed NCT04125537 - Pathways Project: Kidney Supportive Care
Suspended NCT05915286 - Diuretic Use in Hemodialysis Patients With Residual Renal Function Phase 4
Completed NCT04912050 - EXtension of Tablo TrEatmeNt Duration Registry
Recruiting NCT04360694 - RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE) N/A
Recruiting NCT04501159 - pH, Hypoxia and Haemodialysis
Recruiting NCT05032651 - Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients N/A
Completed NCT04806126 - Evaluation of a Virtual Home Dialysis Mentoring Program (Home)